Yahoo Finance • 4 hours ago
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Dividend Stocks with Yields Above 4%.Bristol-Myers Squibb (BMY): Strong Growth Pipeline Supports High-Yield Dividend Bristol-Myers Squibb Company (NYSE:BMY), headquarte... Full story
Yahoo Finance • 20 hours ago
PRINCETON, N.J., October 13, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress 2025 to b... Full story
Yahoo Finance • 22 hours ago
REDMOND, Wash., Oct. 13, 2025 /PRNewswire/ -- SystImmune, Inc., a clinical-stage biotechnology company, today announced the treatment of the first patient in the IZABRIGHT-Breast01 study (NCT06926868), a global Ph2/3 registrational study o... Full story
Yahoo Finance • yesterday
Bristol-Myers Squibb (BMY) shares have experienced a gradual slide over the past month, dipping nearly 5%. Investors are weighing recent developments and financial trends as they look for signs of a possible turnaround. See our latest ana... Full story
Yahoo Finance • yesterday
[Genetic research and Biotech science Concept. Human Biology and pharmaceutical technology] jittawit.21 What's the most attractive biotech stock right now for investors? Seeking Alpha analysts ONeil Trader [https://seekingalpha.com/autho... Full story
Yahoo Finance • 2 days ago
Tom Werner Wall Street's major averages plummeted on Friday after U.S. President Donald Trump threatened higher tariffs to China, saying it had "become very hostile" sending letters to other countries wanting to "impose export controls."... Full story
Yahoo Finance • 2 days ago
Here's a list of key deals reported across sectors this week: * Protagonist Therapeutics (NASDAQ:PTGX [https://seekingalpha.com/symbol/PTGX]), a biotech focused on peptide-based therapeutics, traded ~30% higher on Friday after The Wall... Full story
Yahoo Finance • 3 days ago
Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap stocks to buy for the next 5 years. On October 2, Bristol Myers Squibb announced a development in its Alzheimer’s program: its experimental drug, BMS-986446, received Fast Track d... Full story
Yahoo Finance • 3 days ago
Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 4 days ago
Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story
Yahoo Finance • 4 days ago
Bristol-Myers Squibb (BMY) on Friday agreed to acquire privately-held ribonucleic acid medication ma PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 4 days ago
BMS and NCPA to address cardiovascular disease and enhance patient care coordination with specialized training in rural Alabama, Arkansas, Kentucky, Louisiana, Mississippi, and Missouri pharmacies Originally published on NCPA.org NORTHAM... Full story
Yahoo Finance • 4 days ago
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases Transaction further strengthens BMS’s industry-leading ce... Full story
Yahoo Finance • 5 days ago
Thinking about what to do with Bristol-Myers Squibb stock? You are certainly not alone. With shares closing recently at $44.54, there has been plenty to talk about, especially as the stock has faced some turbulence throughout 2025. Over th... Full story
Yahoo Finance • 7 days ago
Worawith Ounpeng MapLight Therapeutics (MPLT [https://seekingalpha.com/symbol/MPLT]), whose lead candidate ML-007C-MA could potentially rival Bristol Myers’ (BMY [https://seekingalpha.com/symbol/BMY]) recently approved antipsychotic Coben... Full story
Yahoo Finance • 7 days ago
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to examine Bristol-Myers Squibb Company (N... Full story
Yahoo Finance • 7 days ago
In recent trading, shares of TMC The Metals Co Inc (Symbol: TMC) have crossed above the average analyst 12-month target price of $7.69, changing hands for $7.72/share. When a stock reaches the target an analyst has set, the analyst logica... Full story
Yahoo Finance • 8 days ago
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Plug Power Inc. 155,000,553 4.58 3.85 3.8888 +0.0788 Advanced Micro Devi... Full story
Yahoo Finance • 8 days ago
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Best Affordable Dividend Stocks to Buy Now.Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks Bristol-Myers Squibb Company (NYSE:BMY) is a... Full story
Yahoo Finance • 8 days ago
[Pfizer HQ in New York City] georgeclerk What's the most attractive Big Pharma stock right now? We asked Seeking Alpha analysts The Value Portfolio [https://seekingalpha.com/author/the-value-portfolio] and ALLKA Research [https://seeking... Full story